The immunogenic potential of generic version of low-molecular-weight heparins may not be the same as the branded products

被引：4

作者：

Fareed, Jawed ^{[1
]}

Bick, Rodger L. ^{[2
]}

Rao, Gundu

Goldhaber, Samuel Z. ^{[3
]}

Sasahara, Arthur ^{[3
]}

Messmore, Harry L. ^{[1
]}

Happensteadt, Debra A. ^{[1
]}

Nicolaides, Andrew ^{[4
]}

机构：

[1] Loyola Univ, Med Ctr, Thrombosis & Thrombosis Labs, Maywood, IL 60153 USA

[2] Univ Texas Dallas, Dept Med, Dallas Thrombosis Thrombosis Clin Ctr, Dallas, TX 75230 USA

[3] Harvard Univ, Sch Med, Boston, MA USA

[4] Univ Cyprus, Nicosia, Cyprus

来源：

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 2008年 / 14卷 / 01期

关键词：

D O I：

10.1177/1076029607312278

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：5 / 7

页数：3

共 23 条

[1] Differential prevalence of anti-heparin-PF4 immunoglobulin subtypes in patients treated with clivarin and heparin: Implications in the HIT pathogenesis [J].

Ahmad, S ;

Untch, B ;

Haas, S ;

Hoppensteadt, DA ;

Misselwitz, F ;

Messmore, HL ;

Walenga, JM ;

Fareed, J .

MOLECULAR AND CELLULAR BIOCHEMISTRY, 2004, 258 (1-2) :163-170

[2] Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies [J].

Ahmad, S ;

Haas, S ;

Hoppensteadt, DA ;

Lietz, H ;

Reid, U ;

Bender, N ;

Messmore, HL ;

Misselwitz, F ;

Bacher, P ;

Gaikwad, BS ;

Jeske, WP ;

Walenga, JM ;

Fareed, J .

THROMBOSIS RESEARCH, 2002, 108 (01) :49-55

[3]

Ahmad S, 2003, ARCH PATHOL LAB MED, V127, P584

[4]

Amiral J, 1996, AM J HEMATOL, V52, P90, DOI 10.1002/(SICI)1096-8652(199606)52:2<90::AID-AJH4>3.3.CO

[5]

2-5

[6]

Bauer TL, 1997, CIRCULATION, V95, P1242

[7] Titre of anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems [J].

Chilver-Stainer, L ;

Lämmle, B ;

Alberio, L .

THROMBOSIS AND HAEMOSTASIS, 2004, 91 (02) :276-282

[8] Generic low molecular weight heparins: A significant dilemma [J].

Fareed, J ;

Iqbal, O ;

Nader, H ;

Mousa, S ;

Wahi, R ;

Coyne, E ;

Bick, RL .

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2005, 11 (04) :363-366

[9] Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery [J].

Francis, JL ;

Palmer, GJ ;

Moroose, R ;

Drexler, A .

ANNALS OF THORACIC SURGERY, 2003, 75 (01) :17-22

[10] Incidence of antiplatelet factor 4/heparin antibody induction in patients undergoing percutaneous coronary revascularization [J].

Gluckman, TJ ;

Segal, JB ;

Fredde, NL ;

Saland, KE ;

Jani, JT ;

Walenga, JM ;

Prechel, MM ;

Citro, KM ;

Zidar, DA ;

Fox, E ;

Schulman, SP ;

Kickler, TS ;

Rade, JJ .

AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (06) :744-747

← 1 2 3 →